Free Corporate Rating

Free Corporate Rating

Discover how companies are aligning with the Paris Agreement’s goal of limiting global warming to 2°C. This tool provides you with up-to-date climate ratings, reflecting a company’s progress and commitment to sustainable practices. Whether you're an investor, policymaker, or eco-conscious consumer, our platform simplifies your search for transparent, data-driven insights on corporate climate performance.
Start exploring now and make informed decisions for a sustainable future !

Walvax Biotechnology Co., Ltd.

Health Care

ISIN

CNE100000WN2

LEI

300300H82R2DIQXA8N24

Description

Walvax Biotechnology Co., Ltd. is a Chinese biotechnology company that specializes in the research, development, and production of vaccines and other biopharmaceuticals. They also provide services such as contract manufacturing, clinical trial management, and regulatory affairs consulting.
Transitioning
• Condition: 2°C ≤ SB2A < 3°C and decreasing GHG intensity without any target • Description: Transitioning companies, despite the absence of a reduction target, are engaged in reducing their carbon footprint. The decrease in the GHG intensity at issuer level is the sign that these companies are making strides toward sustainability, even if a specific reduction target is yet to be formalized.

Rating peers in sector of Health Care (based on 275 companies)

19%
Leader
7%
Aligned
4%
Actively
transitioning
Walvax Biotechnology Co., Ltd.
29%
Transitioning
35%
Not
aligned
7%
Laggard

Discover other companies in Health Care with Transitioning score

Get in touch!

Want to know more? Fill out the form or reach us directly via email at contact@icebergdatalab.com.

France
ICEBERG DATA LAB
87 Rue Saint-Lazare
75009 Paris
📞 +33 1 89 71 64 00
United Kingdom
ICEBERG DATA LAB
1 Fore Street Avenue
EC2Y 9DT London
📞 +44 20 4634 7956
Germany
ICEBERG DATA LAB
Platz der Einheit 2
60327 Frankfurt am Main, Frankfurt
United States
ICEBERG DATA LAB
100 Cummings Center
Beverly, MA 01915
📞 +1 (351) 235-2879